FDA rejects Lykos MDMA therapy, asks for another Phase III trial
The company plans to ask the US FDA to reconsider its request for an additional Phase III trial for the approval of its MDMA capsules.
The company plans to ask the US FDA to reconsider its request for an additional Phase III trial for the approval of its MDMA capsules.
What's Your Reaction?
